Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 7/20 | 0.34 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.32 |
| ▸ | BTK | Q06187 | 2/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23282793 | 0.86 | TSPO (0.37) | PTGER4 | |
| SCHEMBL26005669 | 0.85 | PTGER4 (0.35) | PTGER4 | |
| SCHEMBL23282842 | 0.85 | KDM4E (0.36) | PTGER4 | |
| SCHEMBL15580555 | 0.84 | — | — | |
| SCHEMBL19309082 | 0.83 | PTGER4 (0.34) | PTGER4CHEK2BTKPIK3CDPIK3CA | |
| SCHEMBL24382566 | 0.81 | PTGER4 (0.34) | PTGER4 | |
| SCHEMBL24277902 | 0.81 | KDM4E (0.38) | PTGER4 | |
| SCHEMBL23676832 | 0.81 | PTGER4 (0.33) | PTGER4 | |
| SCHEMBL21266004 | 0.81 | PTGER4 (0.33) | PTGER4CHEK2BTKPIK3CDPIK3R1 | |
| SCHEMBL10042730 | 0.81 | PTGER4 (0.35) | PTGER4CHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230255109-A1 | COMPOUND, COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255109-A1 | COMPOUND, COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD2, OXER1, OR51E2 | PTGER4 623/4885CHEK2 3076/4885BTK 107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.